NM_006758.3:c.470A>C
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 5P and 1B. PP2PP3_ModeratePP5_ModerateBS2_Supporting
The NM_006758.3(U2AF1):c.470A>C(p.Gln157Pro) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: 𝑓 0.000073 ( 0 hom., cov: 8)
Exomes 𝑓: 0.000030 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
U2AF1
NM_006758.3 missense
NM_006758.3 missense
Scores
9
8
1
Clinical Significance
Conservation
PhyloP100: 7.17
Publications
152 publications found
Genes affected
U2AF1 (HGNC:12453): (U2 small nuclear RNA auxiliary factor 1) This gene belongs to the splicing factor SR family of genes. U2 auxiliary factor, comprising a large and a small subunit, is a non-snRNP protein required for the binding of U2 snRNP to the pre-mRNA branch site. This gene encodes the small subunit which plays a critical role in both constitutive and enhancer-dependent RNA splicing by directly mediating interactions between the large subunit and proteins bound to the enhancers. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 4 curated pathogenic missense variants (we use a threshold of 10). The gene has 0 curated benign missense variants. Gene score misZ: 3.8478 (above the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09).
PP3
MetaRNN computational evidence supports a deleterious effect, 0.852
PP5
Variant 21-43094667-T-G is Pathogenic according to our data. Variant chr21-43094667-T-G is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 376024.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000731 AC: 5AN: 68372Hom.: 0 Cov.: 8 show subpopulations
GnomAD3 genomes
AF:
AC:
5
AN:
68372
Hom.:
Cov.:
8
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251350 AF XY: 0.0000442 show subpopulations
GnomAD2 exomes
AF:
AC:
6
AN:
251350
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000297 AC: 13AN: 437688Hom.: 0 Cov.: 5 AF XY: 0.0000478 AC XY: 11AN XY: 230238 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
13
AN:
437688
Hom.:
Cov.:
5
AF XY:
AC XY:
11
AN XY:
230238
show subpopulations
African (AFR)
AF:
AC:
0
AN:
10406
American (AMR)
AF:
AC:
0
AN:
18402
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
13752
East Asian (EAS)
AF:
AC:
0
AN:
31470
South Asian (SAS)
AF:
AC:
0
AN:
46802
European-Finnish (FIN)
AF:
AC:
0
AN:
34414
Middle Eastern (MID)
AF:
AC:
0
AN:
1684
European-Non Finnish (NFE)
AF:
AC:
11
AN:
256740
Other (OTH)
AF:
AC:
2
AN:
24018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000731 AC: 5AN: 68372Hom.: 0 Cov.: 8 AF XY: 0.0000618 AC XY: 2AN XY: 32350 show subpopulations
GnomAD4 genome
AF:
AC:
5
AN:
68372
Hom.:
Cov.:
8
AF XY:
AC XY:
2
AN XY:
32350
show subpopulations
African (AFR)
AF:
AC:
1
AN:
12228
American (AMR)
AF:
AC:
0
AN:
5690
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2084
East Asian (EAS)
AF:
AC:
0
AN:
4184
South Asian (SAS)
AF:
AC:
0
AN:
2422
European-Finnish (FIN)
AF:
AC:
0
AN:
5332
Middle Eastern (MID)
AF:
AC:
0
AN:
164
European-Non Finnish (NFE)
AF:
AC:
4
AN:
34904
Other (OTH)
AF:
AC:
0
AN:
808
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ExAC
AF:
AC:
5
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Mar 15, 2022
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PM1, PP4_MOD, PP3, PP2, PM2_SUP -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
.;H;H;.
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
0.41
.;.;B;.
Vest4
MutPred
0.56
.;Loss of helix (P = 0.028);Loss of helix (P = 0.028);.;
MVP
MPC
2.5
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.